P2.03-12 EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1199
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Brief Report: EGFR and ERBB2 Germline Mutations in Chinese Lung Cancer Patients and Their Roles in Genetic Susceptibility to Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2019English

P2.03-08 Molecular Spectrum of Patients With MSH2 Mutations in Chinese Non-Small Cell Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Braf and erbB2 Mutations Correlate With Smoking Status in Lung Cancer Patients

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Genetic Susceptibility to Lung Cancer

Frontiers in Bioscience - Scholar
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2011English

P1.01-85 the Prevalence of Different EGFR Exon20 Mutations in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.13-46 Comprehensive Investigation of ERBB2 Transmembrane Domain Mutations (V659/G660) in 12,833 Chinese Lung Cancer Patients

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.03-01 Prevalence of EGFR Alterations in Chilean Lung Cancer Patients: A Retrospective Study

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Germline Mutations in Japanese Familial Pancreatic Cancer Patients

Oncotarget
Oncology
2016English

EGFR Mutations Status for Non-Small-Cell Lung Cancer Patients

Sveikatos mokslai
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy